Non-Accredited Education
Understanding Collagen Dressings and their Benefit in Wound Care Complimentary Archived Webcast
Non-Accredited
Issue
- Issue:3
Dear Editor:
In reference to the article by Parsons et al published in the August 2005 issue of WOUNDS [Parsons D, Bowler PG, Myles V, Jones S. Silver antimicrobial dressings in wound management: a comparison of antibacterial, physical, and chemical characteristics. WOUNDS. 2005;17(8):222–232.], we have come upon several shortcomings of the tests and misleading conclusions. We point out 3 as follows:
- Issue:3
Dear Readers: Physical exercise is important for healing chronic1 and acute2 wounds.
- Issue:3
Theoretically, different types of surgical wound dressings serve many functions: protecting the wound from trauma and contamination, reducing the risk of postoperative hematoma and seroma formation, providing compression of dead space, preventing heat and fluid loss, absorbing exudate, limiting wound disruption, and providing an aesthetically pleasing appearance.1 Since no single dressing exemplifies all of these attributes, the characteristics of a particular surgical incision must be assessed to determine which goals are most important.
- PDGF-BB, TGF-β1, and FGF-2 Proteins Elevate Scar Formation in a Rabbit Ear Excessive Scar ModelIssue:3
Excessive cutaneous scarring in the form of hypertrophic scars and keloids is an area of unmet clinical need and continues to pose significant functional, cosmetic, and psychological problems for many patients and surgeons.1,2 Numerous surgical and pharmacological strategies have been employed to treat excessive scars as reviewed by Tsao et al.3 The molecular signals that cause an active wound healing process to turn off in the process of scar maturation are unknown, and the biology of excessive scarring remains enigmatic to scientists and physicians.
- Issue:3
The 2 cases presented here represent extremes in the presentation of malignant transformation in chronic wounds and serve as important reminders of the need for wound care clinicians to aggressively evaluate and manage chronic wounds of any etiology that follow a stagnant or progressive course.
- Issue:3
Topical antibiotics have been used in wound care for many years. A number of reports have indicated the effectiveness of topical antibiotics for prevention of infection in surgical and traumatic wounds.1–3 However, many authors do not prefer the use of topical antibiotics because of the risk of development of resistance and possibility of hypersensitivity reactions.1,4 Nitrofurazone- and rifamycin-absorbed gauze dressing is commonly used in Turkey, but the literature and data supporting this mode of therapy is lacking.
Press Release
ConvaTec and Boehringer Technologies Announce License Agreement
ConvaTec Acquires Exclusive Worldwide Rights for a Negative Pressure Wound Therapy System
SKILLMAN, NJ (December 18, 2008) — ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a long-term global exclusive license agreement with Boehringer Technologies to market and distribute Boehringer’s Engenex® Negative Pressure Wound Therapy (NPWT) System incorporating Bio-Dome™ Interface Technology.
WOUNDS News Wire
- Friday, December 5, 2008 - 15:08
- Wednesday, October 22, 2008 - 15:28
- Wednesday, October 22, 2008 - 15:25
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"
Upcoming Live Accredited Webcast with Q&A Noon to 1 p.m. EDT January 20, 2009 Rebroadcasts 7:30-8:30 p.m. EDT 3-4 p.m. EDT This activity is supported by an educational grant from Advanced Biohealing. To register for this Webcast, visit www.naccme.com/program/n-550/ |
| MRSA And Diabetic Foot Wounds: Where Do We Go From Here? Accredited Webcast Archive Version available now. This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME). |
|
PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies Maintenance Debridement: A New Look at Science and Art Accredited Webcast with Q&A: November 17, 2008 at 3:00pm EST This activity is supported by an educational grant from HealthPoint Ltd. |








